Skip to content
OpenCapital
Get started

Enliven Therapeutics ELVN Receivables From Stock Option Exercises Included In Prepaid Expenses And Other Current Assets

Other financials

Income statement

See full
Operating income-$27.8M+12.2%
Net income-$23.6M+17.2%
EPS (diluted)-$0.38+33.3%

Balance sheet

See full
Cash & equivalents$132.2M+30.0%
Total debt$302.0K-56.9%
Total equity$453.4M+57.3%
Total assets$464.9M+53.6%

Cash flow

See full
Operating cash flow-$19.3M+20.0%
CapEx--100%
Free cash flow-$19.3M+20.1%

Valuation

See full
Market cap$3.47B+143%
Enterprise value$3.34B+156%

Returns & leverage

See full
Return on equity-26.6%-3.5pp
Debt / equity0×0.0×
Current ratio40.3×+19.3×

Where this comes from

Reported directly by Enliven Therapeutics in its filing.

Tagged under the XBRL concept elvn:ReceivablesFromStockOptionExercisesIncludedInPrepaidExpensesAndOtherCurrentAssets.

The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's receivables from stock option exercises included in prepaid expenses and other current assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enliven Therapeutics's receivables from stock option exercises included in prepaid expenses and other current assets?
Enliven Therapeutics (ELVN) reported receivables from stock option exercises included in prepaid expenses and other current assets of $658K in Q1 2026.